ARTICLE | Company News
Icagen, Pfizer deal
October 4, 2010 7:00 AM UTC
The partners extended to 2011 a 2007 deal to discover, develop and commercialize compounds that modulate three specific sodium ion channels to treat pain and related disorders. Icagen will receive an ...